| Anca Balasu, MD | |
|
2415 Ne 134th St Ste 301, Vancouver, WA 98686-3029 | |
| (360) 882-2778 | |
| Not Available |
| Full Name | Anca Balasu |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 29 Years |
| Location | 2415 Ne 134th St Ste 301, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093710634 | NPI | - | NPPES |
| 8433740 | Medicaid | WA | |
| 023269 | Medicaid | OR | |
| 1002151 | Medicaid | WA | |
| 8906765 | Other | WA | CRIME VICTIMS |
| 0199580 | Other | WA | LABOR & IND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | MD00045183 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Vancouver Clinic Inc Ps | 3173436490 | 471 |
News Archive
More than one-third of teenagers with treatment-resistant depression - many of whom had been depressed for more than two years - became symptom-free six months after switching their medication or combining a medicine switch with cognitive behavioral therapy during a multicenter study led by UT Southwestern Medical Center researchers.
Few researchers doubt the potential for nanoparticles to revolutionize the way anticancer drugs and imaging agents are delivered to tumors.
Luminex Corporation today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. GenturaDx is in late stage development of a fully integrated, highly automated, real-time PCR system that employs a single-use cassette for true sample-to-answer workflow.
Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.
› Verified 4 days ago
| Entity Name | The Vancouver Clinic Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992759427 PECOS PAC ID: 3173436490 Enrollment ID: O20031111000793 |
News Archive
More than one-third of teenagers with treatment-resistant depression - many of whom had been depressed for more than two years - became symptom-free six months after switching their medication or combining a medicine switch with cognitive behavioral therapy during a multicenter study led by UT Southwestern Medical Center researchers.
Few researchers doubt the potential for nanoparticles to revolutionize the way anticancer drugs and imaging agents are delivered to tumors.
Luminex Corporation today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. GenturaDx is in late stage development of a fully integrated, highly automated, real-time PCR system that employs a single-use cassette for true sample-to-answer workflow.
Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.
› Verified 4 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720056187 PECOS PAC ID: 5890689293 Enrollment ID: O20040209000272 |
News Archive
More than one-third of teenagers with treatment-resistant depression - many of whom had been depressed for more than two years - became symptom-free six months after switching their medication or combining a medicine switch with cognitive behavioral therapy during a multicenter study led by UT Southwestern Medical Center researchers.
Few researchers doubt the potential for nanoparticles to revolutionize the way anticancer drugs and imaging agents are delivered to tumors.
Luminex Corporation today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. GenturaDx is in late stage development of a fully integrated, highly automated, real-time PCR system that employs a single-use cassette for true sample-to-answer workflow.
Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.
› Verified 4 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609061969 PECOS PAC ID: 8820178288 Enrollment ID: O20080110000429 |
News Archive
More than one-third of teenagers with treatment-resistant depression - many of whom had been depressed for more than two years - became symptom-free six months after switching their medication or combining a medicine switch with cognitive behavioral therapy during a multicenter study led by UT Southwestern Medical Center researchers.
Few researchers doubt the potential for nanoparticles to revolutionize the way anticancer drugs and imaging agents are delivered to tumors.
Luminex Corporation today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. GenturaDx is in late stage development of a fully integrated, highly automated, real-time PCR system that employs a single-use cassette for true sample-to-answer workflow.
Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anca Balasu, MD Po Box 4825, Portland, OR 97208-4825 Ph: (360) 882-2778 | Anca Balasu, MD 2415 Ne 134th St Ste 301, Vancouver, WA 98686-3029 Ph: (360) 882-2778 |
News Archive
More than one-third of teenagers with treatment-resistant depression - many of whom had been depressed for more than two years - became symptom-free six months after switching their medication or combining a medicine switch with cognitive behavioral therapy during a multicenter study led by UT Southwestern Medical Center researchers.
Few researchers doubt the potential for nanoparticles to revolutionize the way anticancer drugs and imaging agents are delivered to tumors.
Luminex Corporation today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. GenturaDx is in late stage development of a fully integrated, highly automated, real-time PCR system that employs a single-use cassette for true sample-to-answer workflow.
Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.
› Verified 4 days ago
Valentin Y Avramov, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6926 Ne Fourth Plain Blvd, Vancouver, WA 98661 Phone: 360-993-3000 Fax: 360-993-3047 | |
Pippa Macdonald, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 Se 172nd Ave Ste 220, Vancouver, WA 98684 Phone: 360-882-2778 | |
Dr. Michael Dennis Domash, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2215 Broadway St, Vancouver, WA 98663 Phone: 360-906-7156 Fax: 360-696-3658 | |
Duncan Borland, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 505 Ne 87th Ave, Ste. 460, Vancouver, WA 98664 Phone: 360-256-8865 Fax: 360-256-7127 | |
Dr. Bonnie Suzanne Huber, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12607 Se Mill Plain Blvd, Northwest Permanente, Vancouver, WA 98684 Phone: 360-896-4460 Fax: 360-896-4478 | |
Bruce C. Johnson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 748 Se Fairwinds Loop, Vancouver, WA 98661 Phone: 360-695-8476 Fax: 360-567-3033 |